nafamostat has been researched along with malondialdehyde in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dabrowski, A; Gabryelewicz, A | 1 |
Fukuda, H; Kadoba, K; Masai, T; Matsuda, H; Ohata, T; Sawa, Y; Shimazaki, Y; Taniguchi, K | 1 |
1 trial(s) available for nafamostat and malondialdehyde
Article | Year |
---|---|
Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations.
Topics: Benzamidines; Cardiopulmonary Bypass; CD18 Antigens; Complement Hemolytic Activity Assay; Coronary Artery Bypass; Creatine Kinase; Cytokines; Fibrinolysin; Guanidines; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Isoenzymes; Malondialdehyde; Middle Aged; Myocardial Reperfusion Injury; Neutrophil Activation; Serine Proteinase Inhibitors; Tumor Necrosis Factor-alpha | 1996 |
1 other study(ies) available for nafamostat and malondialdehyde
Article | Year |
---|---|
The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
Topics: Acute Disease; Animals; Benzamidines; Gabexate; Guanidines; Lung; Male; Malondialdehyde; Oxidative Stress; Pancreas; Pancreatitis; Rats; Rats, Wistar; Sulfhydryl Compounds; Taurocholic Acid | 1994 |